Diabetes Mellitus, Type 2 Clinical Trials in Singapore
7 recruitingSingapore, Singapore
Showing 1–7 of 7 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1155 locationsNCT07064473
Recruiting
Phase 1
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
ObesityDiabetes Mellitus, Type 2Overweight
Eli Lilly and Company40 enrolled1 locationNCT07299084
Recruiting
A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants
Diabetes Mellitus, Type 2
Novo Nordisk A/S400 enrolled1 locationNCT07532863
Recruiting
Not Applicable
App-based Diabetes Management and Community-based Interventions
Diabetes Mellitus, Type 2
Singapore General Hospital150 enrolled2 locationsNCT06688903
Recruiting
Not Applicable
App-based Motivational Interviewing and Artificial Intelligence in Diabetes Management
Diabetes Mellitus, Type 2
Singapore General Hospital525 enrolled3 locationsNCT06214520
Recruiting
Not Applicable
The PACT (Patient Activation Through Conversations) Study
Diabetes MellitusDiabetes Mellitus, Type 2
National Healthcare Group Polyclinics432 enrolled3 locationsNCT06444074
Recruiting
Not Applicable
Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
Diabetes Mellitus, Type 2
Singapore General Hospital400 enrolled3 locationsNCT06028139